Bustamante, Regine Fher S.

HRN: 21-22-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
CEFUROXIME 750MG (VIAL)
04/08/2024
04/14/2024
IVTT
310mg
Q8h
UTI
Checking Final Appropriateness 
04/11/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/11/2024
04/18/2024
ORAL
1mL
Q4H
Oral Thrush
Checking Final Appropriateness 
04/13/2024
MUPIROCIN 2%, 15G (TUBE)
04/13/2024
04/19/2024
TOPICAL
2%
BID
Previous Iv Site
Waiting Final Action 
04/13/2024
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
04/13/2024
04/19/2024
TOPICAL
20mg/g
BID
Post Iv Site
Waiting Final Action 
04/13/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
04/13/2024
04/17/2024
PO
2.5ml As Single Dose, Then 1.2ml OD X 4 Days
5 Days
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: